BackKuros Biosciences AG Overview

Kuros Biosciences AG Total Current Liabilities

Track Kuros Biosciences AG's total current liabilities ($36M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$35.86M
↑ 32.85% YoYΔ $8.87M vs prior year quarter

Peer trimmed avg / median

Loading

Kuros Biosciences AG Total Current Liabilities History

Loading

Kuros Biosciences AG vs. peers: Total Current Liabilities Comparison

Loading

Kuros Biosciences AG Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Kuros Biosciences AG (CSBTF) FAQ

As of the most recent data (June 2026), CSBTF shows a total current liabilities of $36M. That compares with $27M in the prior-year period — up 32.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CSBTF's total current liabilities is now $36M (was $27M) — a 32.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Kuros Biosciences AG is outperforming or lagging.

Tracking CSBTF's total current liabilities over time shows whether Kuros Biosciences AG is scaling, shrinking, or reshaping that part of the business. The current reading is $36M That compares with $27M in the prior-year period — up 32.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Kuros Biosciences AG's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $36M) with ownership activity and broader fundamentals.